K. Bushby, R. Finkel, D. J. Birnkrant, L. E. Case, and P. R. Clemens, Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care, Lancet Neurol, vol.9, pp.177-189, 2010.

K. Bushby, R. Finkel, D. J. Birnkrant, L. E. Case, and P. R. Clemens, Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management, Lancet Neurol, vol.9, pp.77-93, 2010.

S. Cirak, V. Arechavala-gomeza, M. Guglieri, L. Feng, and S. Torelli, Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study, Lancet, vol.378, issue.11, pp.60756-60759, 2011.

N. M. Goemans, M. Tulinius, J. T. Van-den-akker, B. E. Burm, and P. F. Ekhart, Systemic administration of PRO051 in Duchenne's muscular dystrophy, N Engl J Med, vol.364, pp.1513-1522, 2011.

J. Mendell, L. R. Rodino-klapac, Z. Sahenk, K. Roush, and L. Bird, Eteplirsen for the treatment of duchenne muscular dystrophy, Ann Neurol, 2013.

E. Mercuri and F. Muntoni, Muscular dystrophies, Lancet, vol.381, issue.12, pp.61897-61899, 2013.

C. M. Mcdonald, E. K. Henricson, R. T. Abresch, J. M. Florence, and M. Eagle, The 6-minute walk test and other endpoints in Duchenne muscular dystrophy: Longitudinal natural history observations over 48 weeks from a multicenter study, Muscle Nerve, 2013.

C. M. Mcdonald, E. K. Henricson, J. J. Han, R. T. Abresch, and A. Nicorici, The 6-minute walk test as a new outcome measure in Duchenne muscular dystrophy, Muscle Nerve, vol.41, pp.500-510, 2010.

E. Mercuri, A. Mayhew, F. Muntoni, S. Messina, and V. Straub, Towards harmonisation of outcome measures for DMD and SMA within TREAT-NMD; report of three expert workshops: TREAT-NMD/ENMC workshop on outcome measures, TREAT-NMD workshop on outcome measures in experimental trials for DMD, vol.18, pp.894-903, 2007.

E. Mercuri, C. Mcdonald, A. Mayhew, J. Florence, and E. Mazzone, International workshop on assessment of upper limb function in Duchenne Muscular Dystrophy: Rome, Neuromuscul Disord, vol.22, pp.1025-1028, 2012.

E. S. Mazzone, G. Vasco, C. Palermo, F. Bianco, and C. Galluccio, A critical review of functional assessment tools for upper limbs in Duchenne muscular dystrophy, Dev Med Child Neurol, vol.54, pp.879-885, 2012.

A. Mayhew, E. S. Mazzone, M. Eagle, T. Duong, and M. Ash, Development of the Performance of the Upper Limb module for Duchenne muscular dystrophy, Dev Med Child Neurol, 2013.

M. Pane, E. S. Mazzone, L. Fanelli, D. Sanctis, R. Bianco et al., Reliability of the Performance of Upper Limb assessment in Duchenne muscular dystrophy, Neuromuscul Disord, 2013.

G. Kurillo, J. J. Han, R. T. Abresch, A. Nicorici, and P. Yan, Development and application of stereo camera-based upper extremity workspace evaluation in patients with neuromuscular diseases, PLoS One, vol.7, p.45341, 2012.

G. Kurillo, J. J. Han, A. Nicorici, L. B. Johnson, and R. T. Abresch, Upper extremity reachable workspace evaluation in DMD using Kinect, Neuromuscular Disorders, vol.23, pp.749-750, 2013.

L. P. Lowes, L. N. Alfano, B. A. Yetter, L. Worthen-chaudhari, and W. Hinchman, Proof of concept of the ability of the kinect to quantify upper extremity function in dystrophinopathy, PLoS Curr, vol.5, 2013.

J. E. Mayhew, J. M. Florence, T. P. Mayhew, E. K. Henricson, and R. T. Leshner, Reliable surrogate outcome measures in multicenter clinical trials of Duchenne muscular dystrophy, Muscle Nerve, vol.35, pp.36-42, 2007.

W. A. Stuberg and W. K. Metcalf, Reliability of quantitative muscle testing in healthy children and in children with Duchenne muscular dystrophy using a hand-held dynamometer, Phys Ther, vol.68, pp.977-982, 1988.

B. Bartels, R. F. Pangalila, M. P. Bergen, N. A. Cobben, and H. J. Stam, Upper limb function in adults with Duchenne muscular dystrophy, J Rehabil Med, vol.43, pp.770-775, 2011.

E. Mazzone, F. Bianco, D. Martinelli, A. M. Glanzman, and S. Messina, Assessing upper limb function in nonambulant SMA patients: development of a new module, Neuromuscul Disord, vol.21, pp.406-412, 2011.

M. B. Wagner, P. J. Vignos, C. Carlozzi, and A. L. Hull, Assessment of hand function in Duchenne muscular dystrophy, Arch Phys Med Rehabil, vol.74, pp.801-804, 1993.

E. K. Henricson, R. T. Abresch, A. Cnaan, F. Hu, and T. Duong, The cooperative international neuromuscular research group Duchenne natural history study: glucocorticoid treatment preserves clinically meaningful functional milestones and reduces rate of disease progression as measured by manual muscle testing and other commonly used clinical trial outcome measures, Muscle Nerve, vol.48, pp.55-67, 2013.

O. M. Scott, S. A. Hyde, C. Goddard, and V. Dubowitz, Quantitation of muscle function in children: a prospective study in Duchenne muscular dystrophy, Muscle Nerve, vol.5, pp.291-301, 1982.

G. M. Buyse, N. Goemans, M. Van-den-hauwe, D. Thijs, and I. J. De-groot, Idebenone as a novel, therapeutic approach for Duchenne muscular dystrophy: results from a 12 month, double-blind, randomized placebo-controlled trial, Neuromuscul Disord, vol.21, pp.396-405, 2011.

A. Lerario, S. Bonfiglio, M. Sormani, A. Tettamanti, and S. Marktel, Quantitative muscle strength assessment in duchenne muscular dystrophy: longitudinal study and correlation with functional measures, BMC Neurol, vol.12, p.91, 2012.

L. Servais, N. Deconinck, A. Moraux, M. Benali, and A. Canal, Innovative methods to assess upper limb strength and function in non-ambulant Duchenne patients, Neuromuscul Disord, vol.23, pp.139-148, 2013.

F. Daoud, N. Angeard, B. Demerre, M. I. Benyaou, and R. , Analysis of Dp71 contribution in the severity of mental retardation through comparison of Duchenne and Becker patients differing by mutation consequences on Dp71 expression, Hum Mol Genet, vol.18, pp.3779-3794, 2009.

, ATS statement: guidelines for the six-minute walk test, Am J Respir Crit Care Med, vol.166, pp.111-117, 2002.

S. Chow, J. Shao, and H. Wang, Sample size calculations in clinical research, Chapman & Hall/CRC. xiv, p.465, 2008.

I. Desguerre, C. Christov, M. Mayer, R. Zeller, and H. M. Becane, Clinical heterogeneity of duchenne muscular dystrophy (DMD): definition of sub-phenotypes and predictive criteria by long-term follow-up, PLoS One, vol.4, p.4347, 2009.
URL : https://hal.archives-ouvertes.fr/inserm-00447998

J. M. Dooley, K. E. Gordon, and J. M. Macsween, Impact of steroids on surgical experiences of patients with duchenne muscular dystrophy, Pediatr Neurol, vol.43, pp.173-176, 2010.

R. Roberto, A. Fritz, Y. Hagar, B. Boice, and A. Skalsky, The natural history of cardiac and pulmonary function decline in patients with duchenne muscular dystrophy. Spine (Phila Pa, vol.36, pp.1009-1017, 1976.

C. Vuillerot, C. Payan, F. Girardot, J. Fermanian, and J. Iwaz, Responsiveness of the motor function measure in neuromuscular diseases, Arch Phys Med Rehabil, vol.93, p.2251, 2012.
URL : https://hal.archives-ouvertes.fr/hal-00801436

M. Pane, E. S. Mazzone, M. P. Sormani, S. Messina, and G. L. Vita, 6 minute walk test in duchenne MD patients with different mutations: 12 month changes, PLoS One, vol.9, p.83400, 2014.

F. L. Mattar and C. Sobreira, Hand weakness in Duchenne muscular dystrophy and its relation to physical disability, Neuromuscul Disord, vol.18, pp.193-198, 2008.

V. Humbertclaude, D. Hamroun, K. Bezzou, C. Berard, and O. Boespflug-tanguy, Motor and respiratory heterogeneity in Duchenne patients: implication for clinical trials, Eur J Paediatr Neurol, vol.16, pp.149-160, 2012.
URL : https://hal.archives-ouvertes.fr/hal-01681808